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Background: Serrated lesions of the colorectum as categorized by pathology include hyperplastic polyps, sessile
serrated adenomas without dysplasia, and traditional serrated adenomas with dysplasia. The aim of this study was
to investigate the prevalence of various subtypes of serrated lesions by age.
Methods: In this study, 28,544 consecutive asymptomatic patients (aged 22–88 years) were evaluated during health
check-ups involving colonoscopies performed by gastroenterologists at a single institution from 2005 to 2012.
Results: The adenoma detection rate during colonoscopies for patients aged ≥50 years was 31.8% (25.0–35.8%).
The serrated lesion detection rate for patients aged ≥50 years was 15.3% (10.5–19.6%). Serrated lesions were
detected in 15.1% of all patients with subtype prevalences of 14.7% for hyperplastic polyps, 0.5% for sessile serrated
adenomas, and 0.1% for traditional serrated adenomas. The prevalence of conventional adenomas increased sharply
with age (5.0% in patients aged 20–29 years, 10.9% in those aged 30–39 years, 21.8% in those aged 40–49 years,
29.5% in those aged 50–59 years, 36.9% in those aged 60–69 years, and 40.7% in those aged ≥70 years) (trend P = 0.027).
In contrast, the prevalence of serrated lesions increased only slightly with age (10.0% in patients aged 20–29 years, 11.8%
in those aged 30–39 years, 14.8% in those aged 40–49 years, 15.3% in those aged 50–59 years, 16.8% in those aged
60–69 years, and 16.4% in those aged ≥70 years) (trend P = 0.036).
Conclusions: The screening colonoscopy detection rate of serrated lesions, including sessile serrated adenomas and
traditional serrated adenomas, appears to be relatively high among young patients aged <50 years.
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The incidence and mortality rates associated with colorectal
cancer are rapidly rising in Korea [1]. The current Korean
guidelines recommend the performance of screening
colonoscopy beginning at age 50 years in the average-
risk population [2]. Screening colonoscopy reportedly
facilitates early detection and prevention of colorectal
cancer that develops from the adenoma–carcinoma
pathway [3,4]. However, right-sided colorectal cancer
that develops from the serrated pathway may be less
effectively detected by screening colonoscopy [5].* Correspondence: cecilup@naver.com
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reproduction in any medium, provided the orSerrated lesions of the colorectum are classified into
three heterogeneous categories according to the World
Health Organization: conventional hyperplastic polyps, ses-
sile serrated adenomas, and traditional serrated adenomas
[6]. Serrated lesions have a distinct endoscopic appearance.
Sessile serrated adenomas are flat or sessile, poorly demar-
cated, and waxy or pale, and they may be covered with a
mucus cap. Traditional serrated adenomas are occasionally
peduculated. The detection rate of serrated lesions is
closely dependent on the endoscopist.
An effective colonoscopy is necessary for early diagnosis
of colorectal cancer precursor lesions, adenomas, or
serrated lesions. The adenoma detection rate has been
validated by endoscopists as a predictor of interval cancer
and a surrogate indicator of the quality of screening col-
onoscopy [7,8]. Wide variability in the adenoma detection. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Kim et al. BMC Gastroenterology 2014, 14:82 Page 2 of 6
http://www.biomedcentral.com/1471-230X/14/82rate exists among endoscopists in previous studies [9,10],
and the adenoma detection rate has also shown a strong
correlation with serrated lesion detection rate. Moreover,
a recent study showed that the serrated lesion detection
rate is an important indicator of the quality of colonos-
copy [11].
The aim of this study was to investigate the prevalence
of various serrated lesion subtypes according to age and




The study population comprised all patients who underwent
colonoscopies in a single tertiary hospital (Seoul National
University Bundang Hospital) from January 2005 to August
2012. In total, 28,544 asymptomatic patients aged 22 to
88 years at average risk for colorectal cancer underwent
a complete screening colonoscopy. All patients filled
out a questionnaire regarding their family history of
colorectal cancer, physical activity, alcohol drinking
habits, smoking habits, and hormone use. With respect
to smoking, each patient was categorized as a never-
smoker, former smoker, or current smoker. Seoul National
University Bundang Hospital Health Promotion Center
provided the various examination packages that were
required, including that for colonoscopy. All screened
patients underwent colonoscopy on a volunteer or
employer-sponsored basis regardless of age; the most
important issue among the study population was the
cost of colonoscopy ($US 60 in Korea). This study was
approved by the Institutional Review Board of Seoul
National University Bundang Hospital.
Colonoscopy
Four expert gastroenterologists (>1,000 colonoscopies)
who were certified by the Korean Society of Gastrointes-
tinal Endoscopy and one nonexpert endoscopist (<300
colonoscopies) performed all endoscopies (CF-Q260AI/
AL; Olympus, Tokyo, Japan) with images displayed on
standard-definition video monitors. Patients were excluded
from the study if they had hereditary polyposis syndrome,
inflammatory bowel disease, or an incomplete study. Bowel
preparations comprised 4 L of polyethylene glycol-based or
sodium phosphate-based solution. The proximal colon was
defined as that portion proximal to the splenic flexure
(transverse colon, ascending colon, cecum, and ileocecal
valve). Polyps were pathologically defined as adenomas,
serrated lesions, or carcinoid tumors. Adenomas were
classified as tubular, tubulovillous, or villous adenomas
with low- to high-grade dysplasia or as adenocarcinomas.
Serrated lesions were classified as hyperplastic polyps, sessile
serrated adenomas, or traditional serrated adenomas. Ad-
vanced adenomas were defined as large adenomas (≥10 mmin size); adenomas with histopathological findings of tubulo-
villous, villous, or high-grade dysplasia; or adenocarcinoma.
Endoscopists used the open-biopsy forceps method to esti-
mate the size of the polyp or measure the actual size of the
polyp after removal during colonoscopic polypectomy.
Statistical analyses
Data analyses were performed using SPSS software
(version 18.0; SPSS Inc., Chicago, IL, USA). Continuous
variables are expressed as mean ± standard deviation,
while categorical variables are expressed as absolute values
and percentages. Continuous variables are presented as
medians and ranges, and categorical variables are pre-
sented as percentages. Differences between variables were
assessed by the χ2 test. All P values were two-sided, and a
P value of <0.05 was considered statistically significant.
Results
This study included 28,544 patients (17,357 [60.8%] men;
mean age, 52 ± 10 years) who underwent health check-ups
in a single endoscopy unit for screening colonoscopy. In
total, 18,689 polyps were found in 10,358 of the 28,544 pa-
tients (36.3% of patients). Among these polyps, 71.4% were
proximal polyps and 5.0% were large polyps (≥10 mm).
Serrated lesions accounted for 42% of all colonic polyps.
Table 1 shows the differences in demographics and clinical
characteristics between the patients with adenomatous
polyps and those with serrated lesions. The patients with
serrated lesions were more likely to be young, smokers
(current or former), and alcohol drinkers (P < 0.001).
Adenoma and serrated lesion detection rates by
endoscopists
Table 2 depicts the prevalence of adenomas and serrated
lesions according to pathology, location, and size by col-
onoscopy. In total, 7,830 adenomas were detected in
28,544 patients (27.4%), and 51 colorectal cancers were
detected (0.2%). The adenoma detection rate among pa-
tients of all ages was 27.4%, whereas that in patients
aged ≥50 years was 31.8%.
Table 3 depicts the adenoma and serrated lesion detec-
tion rates by endoscopists. The adenoma detection rate
among patients of all ages was significantly correlated
with the serrated lesion detection rate (R = 0.94, P =
0.020). There was a significant correlation between the
adenoma and serrated lesion detection rates for patients
aged >50 years (R = 0.93, P = 0.022). The highest adenoma
detection rate among all endoscopists was 35.8% in pa-
tients aged ≥50 years. The adenoma detection rate differed
between the four expert endoscopists (31.4%–35.8%)
(endoscopists A, B, C, and D) and the nonexpert endosco-
pist (25.0%) (endoscopist E). Adenomas were proximal in
5,150 (65.8%) patients and distal in 4,904 (62.6%) patients.
The highest serrated lesion detection rate was 19.6% in
Table 1 Demographics and baseline characteristics of patients
Any adenoma Any serrated lesions Adenoma & SL P value
Subjects, n 7775 (27.2%) 4312 (15.1%) 1750 (6.1%)
Age, mean, range, years 55.2 (25–88) 51.4 (22–83) 55.5 (27–82) <0.001
Male,% 67.7 67.9 81.8 <0.001
Current or ex-smokers,% 59.7 65.1 76.5 <0.001
Alcohol use,% 71.8 75.5 21.3 <0.001
Hormone use,% 2.1 2.0 1.0 0.011
Family history of CRC,% 42.8 41.0 43.1 0.256
CRC colorectal cancer, SL serrated lesions.
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tion rate was 15.3%. In patients aged ≥50 years, the ser-
rated lesion detection rate ranged from 14.5% to 19.6%
among the four expert endoscopists and the nonexpert
endoscopist (10.5%).
Serrated lesion subtype detection rate and prevalence by
age decade
In total, 4,312 serrated lesions were detected in 28,544
patients (15.1%). The hyperplastic polyp prevalence rate
was 14.7% (n = 4,187), the sessile serrated adenoma
prevalence rate was 0.5% (n = 143), and the traditional
serrated adenoma prevalence rate was 0.1% (n = 17). Ser-
rated lesions were proximal in 2,241 (52.0%) and distal
in 3,444 (79.9%) patients. Subtype analysis revealed that
more hyperplastic polyps (81.1%) and traditional ser-
rated adenomas (82.4%) were located in the distal colon,
while more sessile serrated adenomas (86.0%) were lo-
cated in the proximal colon. Table 4 shows the serrated
lesion prevalence by age category and sex. There was a
steady trend in the prevalence of serrated lesions with
increasing age (trend P = 0.036) and an increasing trend
in the prevalence of adenomas with age (trend P =
0.027). The serrated lesion prevalence in patients aged
20 to 29 years was 10.0% (22/219), in those aged 30 to
39 years was 11.8% (300/2548), in those aged 40 toTable 2 Polyp prevalence according to location and size by c
Polyp histology Subjects Locatio
10358/28544 Proximal (58.2%)
Adenoma 7830 (27.4%) 5150 (65.8%)
Tubular, low grade 7749 (27.1%) 5139 (66.3%)
Tubular, high grade 19 (0.1%) 16 (84.2%)
Villous/tubulovillous 11 (0.03%) 8 (72.7%)
Adenocarcinoma 51 (0.2%) 31 (60.8%)
Serrated lesions 4312 (15.1%) 2241 (52.0%)
Hyperplastic 4187 (14.7%) 2141 (51.1%)
Sessile serrated adenoma 143 (0.5%) 123 (86.0%)
Traditional serrated adenoma 17 (0.1%) 10 (58.8%)
Carcinoid 26 (0.1%) 4 (15.4%)49 years was 14.8% (1323/8960), in those aged 50 to
59 years was 15.3% (1529/9994), in those aged 60 to
69 years was 16.8% (888/5296), and in those aged
>70 years was 16.4% (250/1527).
Discussion
The present cross-sectional analysis of serrated lesions of
the colorectum at a single institution revealed the preva-
lence of various subtypes of serrated lesions by patient age
and elucidated the detection rates among endoscopists
during screening colonoscopies. The serrated lesion
subtype prevalence in average-risk patients undergoing
screening colonoscopy in the present study was similar to
that previously reported. Serrated lesions were detected in
15.1% of patients, including 14.7% hyperplastic polyps,
0.5% sessile serrated adenomas, and 0.1% traditional
serrated adenomas. Compared with a recently published
study [9] with a detection rate of 11.7% for hyperplastic
polyps, 0.6% for sessile serrated adenomas, and 0.2% for
traditional serrated adenomas, our results emphasize the
effect of screening colonoscopy on the detection rate of
serrated lesion subtypes among gastroenterologists in a
general population-based setting of young to old patients
(range, 22–88 years of age). The age-specific prevalence of
serrated lesions steadily increased with age, while that of
conventional adenomas sharply increased with age.olonoscopy
n (%) Size
Distal (41.8%) ≤9 mm 10-20 mm >20 mm
4904 (62.6%) 7745 (98.9%) 311 (4.0%) 29 (0.4%)
4888 (63.1%) 7736 (99.8%) 302 (3.9%) 20 (0.3%)
14 (73.7%) 19 (100%) 1 (5.3%) 1 (5.3%)
9 (81.8%) 10 (90.9%) 5 (45.5%) 0
42 (82.4%) 35 (68.6%) 21 (41.2%) 19 (37.3%)
3444 (79.9%) 4309 (99.9%) 166 (3.8%) 9 (0.2%)
3395 (81.1%) 4185 (99.9%) 162 (3.9%) 9 (0.2%)
66 (46.2%) 142 (99.3%) 9 (6.3%) 0
14 (82.4%) 17(100%) 2 (11.8%) 0
25 (96.2%) 24 (92.3%) 1 (3.8%) 1 (3.8%)
Table 3 Adenoma and serrated lesion detection rates by endoscopist
Endoscopist n ADR for all subjects (%) SDR for subjects (%) ADR for all subjects (≥50 years) (%) SDR for subjects (≥50 years) (%)
A 6805 30.0 16.6 35.8 17.1
B 6461 26.9 13.5 31.4 14.6
C 5965 29.5 18.8 34.9 19.6
D 6757 26.2 14.6 31.8 14.5
E 2556 20.4 9.7 25.0 10.5
mean 28544 27.4 (20.4-30.0) 15.1 (9.7-18.8) 31.8 (25.0-35.8) 15.3 (10.5-19.6)
R, P value R = 0.94, P = 0.020 R = 0.93, P = 0.022
ADR adenoma detection rate, SDR serrated lesion detection rate, R Pearson’s correlation coefficient.
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the risk of death from colorectal cancer compared with
the general population [6,12]. Colonoscopy does not
reduce the incidence of death caused by right-sided
colorectal cancer [13]. However, recent studies showed
that a long-term effect of colonoscopy and a modest risk
reduction for proximal colon cancer was achieved by
colonoscopy in a United States cohort [5,14] and German
cohort [15]. Colonoscopy performed by a gastroenterolo-
gist was more protective against colorectal cancer mortal-
ity than was colonoscopy performed by other providers.
The adenoma detection rate of ≥20% (≥25% in
men ≥50 years of age and ≥15% in women ≥50 years
of age) during screening colonoscopy, which was devel-
oped as a quality indicator in 2002 [7], has now been vali-
dated as a powerful predictor of the colorectal cancer risk
after screening colonoscopy. In a Polish study [8], the
adenoma detection rate was associated with the risk of
interval cancer during screening colonoscopy. However,
37.5% of those with adenoma detection rates of <11%
had colonoscopic experience of >10 years and 43% of
those with adenoma detection rates <11% for all
endoscopists.
One editorial offered several potential explanations and
possible solutions for the relatively poor protection offeredTable 4 Polyp prevalence by age and sex





Adenoma 7775 (27.2%) 5511 (70.9) 11 (5.0%) 279 (10.9%
Tubular, low grade 7749 (27.1%) 5498 (71.0) 11 279
Tubular, high grade 19 (0.1%) 10 (50) 0 0
Villous/tubulovillous 11 (0.03%) 11 (100) 0 1
Adenocarcinoma 51 (0.2%) 36 (70.6) 0 0
Serrated lesions 4312 (15.1%) 3170 (73.5) 22 (10.0%) 300 (11.8%
Hyperplastic 4187 (14.7%) 3097 (74.0) 21 287
Sessile serrated 143 (0.5%) 86 (60.1) 1 18
Traditional serrated 17 (0.1%) 13 (76.5) 0 2
Carcinoid 26 (0.1%) 17 (65.4) 0 6by colonoscopy against right-sided colon cancer [16].
Some of these explanations included poor proximal colon
protection in the form of poor bowel preparation, incom-
plete cecal intubation, failed detection of flat or depressed
lesions, and failed detection of serrated lesions. These
could be addressed by split dose preparation, documenta-
tion by landmarks, measurement of adenoma detection
rates, measurement of serrated lesion detection rates, and
education on detection of proximal colon serrated lesions.
An ASGE/ACG Taskforce on Quality in Endoscopy pro-
posed that effective endoscopists should achieve a cecal
intubation rate of ≥90% of all cases and ≥95% of screening
colonoscopies [17].
Another explanation for the relatively poor protection
offered by colonoscopy against right-sided colon cancer
is the continuum of molecular changes (CIMP, MSI, and
BRAF mutations) from the rectum to the ascending
colon. This study has a substantial impact on the field of
gastroenterology because of the prevalent dogma of
proximal versus distal dichotomy, which is clearly an
oversimplification [18,19].
The serrated lesion detection rate has a wide range
that is dependent on the endoscopist’s experience and
method. Two recent retrospective studies have evaluated








≥70 (n = 1527)
) 1954 (21.8%) 2958 (29.5%) 1952 (36.9%) 621 (40.7%) 0.027
1951 2948 1940 620
1 8 7 3
2 2 3 3
5 14 26 6
) 1323 (14.8%) 1529 (15.3%) 888 (16.8%) 250 (16.4%) 0.036
1277 1494 866 242
50 45 29 5
6 2 4 3
11 7 2 0
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2010 study [9], 7,192 colonoscopies at a single center
were stratified by 13 endoscopists. The hyperplastic
polyp detection rate ranged from 7.7% to 31.0%, the ses-
sile serrated adenoma detection rate ranged from 0.0%
to 2.2%, and the traditional serrated adenoma detection
rate ranged from 0.0% to 0.5%. Additionally, a 2012
study [11] described 6,681 colonoscopies performed by
15 endoscopists. The proximal serrated lesion detection
rate ranged from 1.0% to 18%. Our study showed a mean
proximal serrated lesion detection rate of 7.9% with a
narrowly ranged serrated lesion detection rate of 14.5%
to 19.6% among the four expert gastroenterologists.
However, the serrated lesion detection rate was wide
when the nonexpert gastroenterologist was included
(10.5%–19.6%). This suggests the effect of the endosco-
pist’s experience. The four expert endoscopists’ numbers
of years of experience were very similar since gastro-
enterology fellowship graduation (range, 9–10 years).
Our data demonstrate that serrated lesions tend to de-
velop more frequently than conventional adenomas in
younger patients (aged 20–39 years). The prevalence of
conventional adenomas increased sharply with age (5.0%
in patients aged 20–29 years, 10.9% in those aged 30–39
years, 21.8% in those aged 40–49 years, 29.5% in those
aged 50–59 years, 36.9% in those aged 60–69 years, and
40.7% in those aged ≥70 years). In contrast, the preva-
lence of serrated lesions increased only slightly with age
(10.0% in patients aged 20–29 years, 11.8% in those aged
30–39 years, 14.8% in those aged 40–49 years, 15.3% in
those aged 50–59 years, 16.8% in those aged 60–69
years, and 16.4% in those aged ≥70 years). This differ-
ence in the age-specific prevalence between serrated le-
sions and conventional adenomas may be due to several
factors. For example, as many as 15% of colorectal
cancers occurred in patients <50 years of age, which is
the age at which we routinely start performing screening
colonoscopy for colon cancers. Additionally, serrated
lesions may be contributors to 15% to 35% of cases of
colorectal cancer development through the serrated
polyp–carcinoma pathway [3,4] and to the majority of
cases of interval cancer development [20].
A strength of the current study is that it is the first to
include patients in a young age category (<50 years of
age) for evaluation of the serrated lesion prevalence
using colonoscopy and precise categorization of the sub-
types of serrated lesions. Importantly, it is the largest such
study to date, comprising 28,544 patients who underwent
screening colonoscopy to determine the age-specific
prevalence of serrated lesions. An additional strength is
that the majority of colonoscopies were performed by
highly experienced endoscopists, producing high-quality
data. All screened patients answered a questionnaire prior
to colonoscopy, suggesting minimum recall bias. However,this study also has some limitations. Its main limitation is
its cross-sectional, retrospective design, which introduces
bias and leads to underestimation of the prevalence of
small, left-sided hyperplastic polyps. A second limitation
is the use of standard-definition white-light colonoscopes.
Whether there is a significant difference between the de-
tection rates of high- and standard-definition white-light
colonoscopy remains unclear. A third limitation is that
observer variation among pathologists in the diagnosis of
serrated lesions could lead to underestimation of the true
prevalence of sessile serrated adenomas and traditional
serrated adenomas and thus to overestimation of the true
prevalence of hyperplastic polyps.
Conclusions
The prevalence of serrated lesions, including sessile serrated
adenomas and traditional serrated adenomas, appears to be
relatively high among young patients aged <50 years by
routine screening colonoscopy.
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